Foresite Capital

United States
cb
Foresite Capital is a multi-stage healthcare and life sciences investment firm that applies rigorous scientific and data-driven approaches to investment analysis. The firm has $2 billion under management. Foresite Capital takes a collaborative approach to investing with its portfolio companies by providing a multidisciplinary team of scientists,engineers, analysts, and clinicians who understand the unique business models in healthcare in addition to capital. The company aims to address areas of great unmet clinical need over the long term by funding promising healthcare and life sciences businesses at all stages of their life cycles. Its portfolio also emphasizes companies that are employing the tools of data science and machine intelligence in healthcare. Foresite Capital is based in San Francisco with an office in New York.
Founded:2011
Firm Location:United States • California • Pennsylvania • Nevada • New Jersey • New York, New York • Los Angeles, California • Philadelphia, Pennsylvania • San Francisco, California • Denver, Colorado • San Francisco Bay Area
Investor Firms That Co-Invest with Foresite Capital
Aisling CapitalRA CapitalCivilization VenturesF-Prime Capital PartnersWildcat VenturesDeerfield ManagementThe Column GroupAtlas VentureARCH Venture PartnersVida VenturesFlare Capital PartnersAndreessen HorowitzVenrockBain Capital Life SciencesNorthpond VenturesvenBioPontifax Venture CapitalMolten VenturesVersant VenturesOrbiMedHOF CapitalGV (Google Ventures)First Round Capital
Foresite Capital Team
Photo of Luke Bagaason, Analyst at Foresite Capital
Luke Bagaason
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO)
Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Colorado / Utah (Other Lists), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
to see your intro paths to Luke
Photo of Vikram Bajaj, Managing Director at Foresite Capital
Vikram Bajaj
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA), Investors in Nevada
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Vikram
Photo of Matthew Buten, Managing Partner at Foresite Capital
Matthew Buten
Foresite Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in New York City (Other Lists)
to see your intro paths to Matthew
Photo of Shoman Kasbekar, Principal at Foresite Capital
Shoman Kasbekar
Foresite Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Shoman
Photo of Rhonda Kaufman, Managing Director at Foresite Capital
Rhonda Kaufman
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New Jersey
to see your intro paths to Rhonda
Photo of Richard Lau, Partner at Foresite Capital
Richard Lau
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in New York City (Other Lists)
to see your intro paths to Richard
Photo of Alisa Mall, Managing Director at Foresite Capital
Alisa Mall
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City, Investors in New York (NY)
to see your intro paths to Alisa
Photo of Dorothy Margolskee, Managing Partner at Foresite Capital
Dorothy Margolskee
Foresite Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New Jersey
to see your intro paths to Dorothy
Photo of Stephen Peterson, Managing Director at Foresite Capital
Stephen Peterson
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO)
Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in Colorado / Utah (Other Lists), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A)
to see your intro paths to Stephen
Photo of Hemaka Rajapakse, Managing Director at Foresite Capital
Hemaka Rajapakse
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Pennsylvania
to see your intro paths to Hemaka
Photo of Michael Rome, Managing Director at Foresite Capital
Michael Rome
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Health IT (Series A)
to see your intro paths to Michael
Photo of Dennis Ryan, Managing Director at Foresite Capital
Dennis Ryan
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in California
to see your intro paths to Dennis
Photo of Linda Shaffer, Managing Director at Foresite Capital
Linda Shaffer
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Linda
Photo of Damien Soghoian, Investor at Foresite Capital
Damien Soghoian
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in Digital Health (Pre-seed), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Pre-seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Damien
Photo of Jim Tananbaum, Investor at Foresite Capital
Jim Tananbaum
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Jim
Photo of Tony Wiemelt, Managing Director at Foresite Capital
Tony Wiemelt
Foresite Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Tony
Photo of Cindy Xiong, Investor at Foresite Capital
Cindy Xiong
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Series B), Investors in Health IT (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
to see your intro paths to Cindy
Photo of Collin Yang-Wong, Analyst at Foresite Capital
Collin Yang-Wong
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
to see your intro paths to Collin
Photo of Brett Zbar, Managing Partner at Foresite Capital
Brett Zbar
Foresite Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in New York City (Other Lists), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health IT (Series A)
to see your intro paths to Brett